Advertisement
WASHINGTON (Reuters) - U.S. health officials have disclosed safety probes into over 20 medicines by companies such as Eli Lilly and Co and Biogen Idec, a step required by Congress to address concerns the agency had been slow to warn of risks.



Discuss   Share This  Tell a friend   Discard



Comments Who Ranked Related Links